Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation

by Dana Prídavková, Matej Samoš, Tomáš Bolek, Ingrid Škorňová, Jana Žolková, Peter Kubisz, Ján Staško, Marián Mokáň
Published 2019-01-01

Type 2 Diabetes and ADP Receptor Blocker Therapy

by Matej Samoš, Marián Fedor, František Kovář, Michal Mokáň, Tomáš Bolek, Peter Galajda, Peter Kubisz, Marián Mokáň
Published 2016-01-01

Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases

by Matej Samoš, Ingrid Škorňová, Tomáš Bolek, Lucia Stančiaková, Barbora Korpallová, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň
Published 2021-01-01

Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?

by Ingrid Škorňová, Matej Samoš, Tomáš Bolek, Lucia Stančiaková, Ľubica Vádelová, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň
Published 2021-05-01

The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study

by Matej Samoš, Marián Fedor, František Kovář, Peter Galajda, Tomáš Bolek, Lucia Stančiaková, Jana Fedorová, Ján Staško, Peter Kubisz, Marián Mokáň
Published 2016-01-01

How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?

by Lucia Stanciakova, Miroslava Dobrotova, Pavol Holly, Jana Zolkova, Lubica Vadelova, Ingrid Skornova, Jela Ivankova, Tomas Bolek, Matej Samos, Marian Grendar, Jan Danko, Peter Kubisz, Jan Stasko
Published 2021-05-01